文传商讯
European Commission Approves TEPMETKO (tepotinib) for Patients with Advanced NSCLC with METex14 Skip
2022-02-22 17:58:04
Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO (avelumab) First-L
2022-02-22 17:58:04
Alofisel▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Stu
2022-02-22 17:58:04
BreastScreen Victoria Switches to Rimini Street Support for its Oracle Database Software, Unlocks Re
2022-02-19 12:57:52